Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2098821956', 'doi': 'https://doi.org/10.1016/s0009-9236(99)90089-9', 'title': 'Quantitative characterization of therapeutic index: Application of mixed-effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships', 'display_name': 'Quantitative characterization of therapeutic index: Application of mixed-effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships', 'publication_year': 1999, 'publication_date': '1999-06-01', 'ids': {'openalex': 'https://openalex.org/W2098821956', 'doi': 'https://doi.org/10.1016/s0009-9236(99)90089-9', 'mag': '2098821956', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/10391673'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0009-9236(99)90089-9', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S159852663', 'display_name': 'Clinical Pharmacology & Therapeutics', 'issn_l': '0009-9236', 'issn': ['0009-9236', '1085-8733', '1532-6535'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5056790291', 'display_name': 'Swati Gupta', 'orcid': 'https://orcid.org/0000-0002-2004-1999'}, 'institutions': [{'id': 'https://openalex.org/I180670191', 'display_name': 'University of California, San Francisco', 'ror': 'https://ror.org/043mz5j54', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I180670191']}, {'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB', 'US'], 'is_corresponding': False, 'raw_author_name': 'S GUPTA', 'raw_affiliation_strings': ['ALZA Corporation, Palo Alto', 'University of California, San Francisco, San Francisco', 'University of Manchester, Manchester'], 'affiliations': [{'raw_affiliation_string': 'University of California, San Francisco, San Francisco', 'institution_ids': ['https://openalex.org/I180670191']}, {'raw_affiliation_string': 'University of Manchester, Manchester', 'institution_ids': ['https://openalex.org/I28407311']}, {'raw_affiliation_string': 'ALZA Corporation, Palo Alto', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072528594', 'display_name': 'Gayatri Sathyan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I180670191', 'display_name': 'University of California, San Francisco', 'ror': 'https://ror.org/043mz5j54', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I180670191']}, {'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB', 'US'], 'is_corresponding': False, 'raw_author_name': 'G SATHYAN', 'raw_affiliation_strings': ['ALZA Corporation, Palo Alto', 'University of California, San Francisco, San Francisco', 'University of Manchester, Manchester'], 'affiliations': [{'raw_affiliation_string': 'University of California, San Francisco, San Francisco', 'institution_ids': ['https://openalex.org/I180670191']}, {'raw_affiliation_string': 'University of Manchester, Manchester', 'institution_ids': ['https://openalex.org/I28407311']}, {'raw_affiliation_string': 'ALZA Corporation, Palo Alto', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065699932', 'display_name': 'Elizabeth Lindemulder', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}, {'id': 'https://openalex.org/I180670191', 'display_name': 'University of California, San Francisco', 'ror': 'https://ror.org/043mz5j54', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I180670191']}], 'countries': ['GB', 'US'], 'is_corresponding': False, 'raw_author_name': 'E LINDEMULDER', 'raw_affiliation_strings': ['ALZA Corporation, Palo Alto', 'University of California, San Francisco, San Francisco', 'University of Manchester, Manchester'], 'affiliations': [{'raw_affiliation_string': 'University of Manchester, Manchester', 'institution_ids': ['https://openalex.org/I28407311']}, {'raw_affiliation_string': 'University of California, San Francisco, San Francisco', 'institution_ids': ['https://openalex.org/I180670191']}, {'raw_affiliation_string': 'ALZA Corporation, Palo Alto', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040618269', 'display_name': 'Pak‐Leung Ho', 'orcid': 'https://orcid.org/0000-0002-8811-1308'}, 'institutions': [{'id': 'https://openalex.org/I180670191', 'display_name': 'University of California, San Francisco', 'ror': 'https://ror.org/043mz5j54', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I180670191']}, {'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB', 'US'], 'is_corresponding': False, 'raw_author_name': 'P HO', 'raw_affiliation_strings': ['ALZA Corporation, Palo Alto', 'University of California, San Francisco, San Francisco', 'University of Manchester, Manchester'], 'affiliations': [{'raw_affiliation_string': 'ALZA Corporation, Palo Alto', 'institution_ids': []}, {'raw_affiliation_string': 'University of California, San Francisco, San Francisco', 'institution_ids': ['https://openalex.org/I180670191']}, {'raw_affiliation_string': 'University of Manchester, Manchester', 'institution_ids': ['https://openalex.org/I28407311']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082579615', 'display_name': 'Lewis B. Sheiner', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}, {'id': 'https://openalex.org/I180670191', 'display_name': 'University of California, San Francisco', 'ror': 'https://ror.org/043mz5j54', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I180670191']}], 'countries': ['GB', 'US'], 'is_corresponding': False, 'raw_author_name': 'L SHEINER', 'raw_affiliation_strings': ['ALZA Corporation, Palo Alto', 'University of California, San Francisco, San Francisco', 'University of Manchester, Manchester'], 'affiliations': [{'raw_affiliation_string': 'University of Manchester, Manchester', 'institution_ids': ['https://openalex.org/I28407311']}, {'raw_affiliation_string': 'ALZA Corporation, Palo Alto', 'institution_ids': []}, {'raw_affiliation_string': 'University of California, San Francisco, San Francisco', 'institution_ids': ['https://openalex.org/I180670191']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5004605882', 'display_name': 'Leon Aarons', 'orcid': 'https://orcid.org/0000-0003-2704-6570'}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}, {'id': 'https://openalex.org/I180670191', 'display_name': 'University of California, San Francisco', 'ror': 'https://ror.org/043mz5j54', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I180670191']}], 'countries': ['GB', 'US'], 'is_corresponding': False, 'raw_author_name': 'L AARONS', 'raw_affiliation_strings': ['ALZA Corporation, Palo Alto', 'University of California, San Francisco, San Francisco', 'University of Manchester, Manchester'], 'affiliations': [{'raw_affiliation_string': 'University of Manchester, Manchester', 'institution_ids': ['https://openalex.org/I28407311']}, {'raw_affiliation_string': 'ALZA Corporation, Palo Alto', 'institution_ids': []}, {'raw_affiliation_string': 'University of California, San Francisco, San Francisco', 'institution_ids': ['https://openalex.org/I180670191']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4000, 'currency': 'USD', 'value_usd': 4000, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 6.103, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 65, 'citation_normalized_percentile': {'value': 0.926292, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '65', 'issue': '6', 'first_page': '672', 'last_page': '684'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10804', 'display_name': 'Health Systems, Economic Evaluations, Quality of Life', 'score': 0.9826, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10804', 'display_name': 'Health Systems, Economic Evaluations, Quality of Life', 'score': 0.9826, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T10838', 'display_name': 'Animal Behavior and Welfare Studies', 'score': 0.9646, 'subfield': {'id': 'https://openalex.org/subfields/3404', 'display_name': 'Small Animals'}, 'field': {'id': 'https://openalex.org/fields/34', 'display_name': 'Veterinary'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11235', 'display_name': 'Statistical Methods in Clinical Trials', 'score': 0.9576, 'subfield': {'id': 'https://openalex.org/subfields/2613', 'display_name': 'Statistics and Probability'}, 'field': {'id': 'https://openalex.org/fields/26', 'display_name': 'Mathematics'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/oxybutynin', 'display_name': 'Oxybutynin', 'score': 0.96852124}, {'id': 'https://openalex.org/keywords/therapeutic-index', 'display_name': 'Therapeutic index', 'score': 0.47245458}, {'id': 'https://openalex.org/keywords/therapeutic-effect', 'display_name': 'Therapeutic effect', 'score': 0.4477659}], 'concepts': [{'id': 'https://openalex.org/C2777844464', 'wikidata': 'https://www.wikidata.org/wiki/Q1060922', 'display_name': 'Oxybutynin', 'level': 4, 'score': 0.96852124}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.67609465}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.51411206}, {'id': 'https://openalex.org/C19831878', 'wikidata': 'https://www.wikidata.org/wiki/Q659446', 'display_name': 'Therapeutic index', 'level': 3, 'score': 0.47245458}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.44827014}, {'id': 'https://openalex.org/C102652120', 'wikidata': 'https://www.wikidata.org/wiki/Q2419430', 'display_name': 'Therapeutic effect', 'level': 2, 'score': 0.4477659}, {'id': 'https://openalex.org/C77411442', 'wikidata': 'https://www.wikidata.org/wiki/Q181100', 'display_name': 'Urinary system', 'level': 2, 'score': 0.43980822}, {'id': 'https://openalex.org/C126894567', 'wikidata': 'https://www.wikidata.org/wiki/Q105650', 'display_name': 'Urology', 'level': 1, 'score': 0.36234805}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.3458044}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.3018912}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.28073752}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.272879}, {'id': 'https://openalex.org/C2778941218', 'wikidata': 'https://www.wikidata.org/wiki/Q331231', 'display_name': 'Overactive bladder', 'level': 3, 'score': 0.2564634}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D018680', 'descriptor_name': 'Cholinergic Antagonists', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D008333', 'descriptor_name': 'Mandelic Acids', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D010276', 'descriptor_name': 'Parasympatholytics', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D014549', 'descriptor_name': 'Urinary Incontinence', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018680', 'descriptor_name': 'Cholinergic Antagonists', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D018680', 'descriptor_name': 'Cholinergic Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008333', 'descriptor_name': 'Mandelic Acids', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D008333', 'descriptor_name': 'Mandelic Acids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010276', 'descriptor_name': 'Parasympatholytics', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010276', 'descriptor_name': 'Parasympatholytics', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012472', 'descriptor_name': 'Salivation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D012472', 'descriptor_name': 'Salivation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014549', 'descriptor_name': 'Urinary Incontinence', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0009-9236(99)90089-9', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S159852663', 'display_name': 'Clinical Pharmacology & Therapeutics', 'issn_l': '0009-9236', 'issn': ['0009-9236', '1085-8733', '1532-6535'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/10391673', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.76}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 7, 'referenced_works': ['https://openalex.org/W1986053715', 'https://openalex.org/W1993147091', 'https://openalex.org/W2065135937', 'https://openalex.org/W2074323366', 'https://openalex.org/W2077508765', 'https://openalex.org/W2100358124', 'https://openalex.org/W214995755'], 'related_works': ['https://openalex.org/W2932067499', 'https://openalex.org/W2610597620', 'https://openalex.org/W2538637255', 'https://openalex.org/W2472682254', 'https://openalex.org/W2407883725', 'https://openalex.org/W2383979496', 'https://openalex.org/W2376052020', 'https://openalex.org/W2350839832', 'https://openalex.org/W22975691', 'https://openalex.org/W2010662326'], 'abstract_inverted_index': {'Clinical': [0, 9, 723], 'Pharmacology': [1, 724], '&': [2, 725], 'TherapeuticsVolume': [3], '65,': [4, 728], 'Issue': [5], '6': [6], 'p.': [7], '672-684': [8, 1019], 'Trial': [10], 'Quantitative': [11], 'characterization': [12], 'of': [13, 17, 43, 50, 78, 85, 106, 113, 132, 139, 160, 167, 186, 193, 217, 224, 252, 259, 280, 287, 306, 313, 334, 341, 360, 367, 405, 415, 428, 439, 481, 570, 669, 746, 786, 798, 804, 830, 856, 860, 887, 964, 1001], 'therapeutic': [14, 458, 523, 712, 754], 'index:': [15], 'Application': [16], 'mixed-effects': [18, 528], 'modeling': [19, 595], 'to': [20, 389, 411, 434, 520, 532, 998], 'evaluate': [21, 521], 'oxybutynin': [22, 499, 535, 649, 654, 680, 685, 717, 837, 865, 891], 'dose–efficacy': [23, 536], 'and': [24, 403, 407, 419, 426, 445, 468, 484, 507, 537, 560, 610, 613, 621, 630, 690, 706, 739, 749, 752, 778, 783, 824, 858, 905, 922, 959, 985], 'dose–side': [25], 'effect': [26, 487, 603, 617], 'relationships': [27], 'Suneel': [28, 34, 202, 208], 'K.': [29, 35, 203, 209, 737], 'Gupta': [30, 36, 204, 210], 'PhD,': [31, 69, 177, 205, 243, 351], 'Corresponding': [32, 206], 'Author': [33, 207], 'PhD': [37, 72, 180, 211, 246, 354], 'ALZA': [38, 73, 101, 127, 155, 181, 212, 247, 275, 301, 329, 355], 'Corporation,': [39, 74, 102, 128, 156, 182, 213, 248, 276, 302, 330, 356], 'Palo': [40, 75, 103, 129, 157, 183, 214, 249, 277, 303, 331, 357], 'Alto': [41, 76, 104, 130, 158, 184, 215, 250, 278, 304, 332, 358], 'University': [42, 49, 77, 84, 105, 112, 131, 138, 159, 166, 185, 192, 216, 223, 251, 258, 279, 286, 305, 312, 333, 340, 359, 366], 'California,': [44, 79, 107, 133, 161, 187, 218, 253, 281, 307, 335, 361], 'San': [45, 47, 80, 82, 108, 110, 134, 136, 162, 164, 188, 190, 219, 221, 254, 256, 282, 284, 308, 310, 336, 338, 362, 364, 917], 'Francisco,': [46, 81, 109, 135, 163, 189, 220, 255, 283, 309, 337, 363], 'Francisco': [48, 83, 111, 137, 165, 191, 222, 257, 285, 311, 339, 365], 'Manchester,': [51, 86, 114, 140, 168, 194, 225, 260, 288, 314, 342, 368], 'Manchester1550': [52, 226], 'Plymouth': [53, 227], 'Road,': [54, 228], 'Mountain': [55, 229], 'View,': [56, 230], 'CA': [57, 231], '94039–7210.': [58, 232], 'E-mail:': [59, 233], '[email': [60, 234], 'protected]Search': [61, 235], 'for': [62, 88, 116, 142, 170, 196, 236, 262, 290, 316, 344, 370, 460, 465, 498, 607, 716, 720, 893, 931, 943], 'more': [63, 89, 117, 143, 171, 197, 237, 263, 291, 317, 345, 371], 'papers': [64, 90, 118, 144, 172, 198, 238, 264, 292, 318, 346, 372], 'by': [65, 91, 119, 145, 173, 199, 239, 265, 293, 319, 347, 373], 'this': [66, 92, 120, 146, 174, 200, 240, 266, 294, 320, 348, 374, 440], 'authorGayatri': [67, 241], 'Sathyan': [68, 71, 242, 245], 'Gayatri': [70, 244], 'ManchesterSearch': [87, 115, 141, 169, 195, 261, 289, 315, 343, 369], 'authorElizabeth': [93, 267], 'A.': [94, 98, 268, 272, 741, 816, 882, 961], 'Lindemulder': [95, 99, 269, 273], 'MS,': [96, 123, 270, 297], 'Elizabeth': [97, 271], 'MS': [100, 126, 274, 300], 'authorPai-Ling': [121, 295], 'Ho': [122, 125, 296, 299], 'Pai-Ling': [124, 298], 'authorLewis': [147, 321], 'B.': [148, 152, 322, 326, 795, 908, 982, 993], 'Sheiner': [149, 153, 323, 327], 'MD,': [150, 324], 'Lewis': [151, 325], 'MD': [154, 328], 'authorLeon': [175, 349], 'Aarons': [176, 179, 350, 353], 'Leon': [178, 352], 'author': [201, 375], 'First': [376, 873], 'published:': [377], '17': [378], 'June': [379], '1999': [380], 'https://doi.org/10.1016/S0009-9236(99)90089-9Citations:': [381], '11Read': [382], 'the': [383, 421, 431, 478, 482, 485, 522, 534, 546, 594, 601, 605, 608, 615, 637, 656, 667, 687, 697, 702, 802, 805, 999], 'full': [384, 395], 'textAboutPDF': [385], 'ToolsRequest': [386], 'permissionExport': [387], 'citationAdd': [388], 'favoritesTrack': [390], 'citation': [391], 'ShareShare': [392], 'Give': [393], 'accessShare': [394, 397], 'text': [396], 'full-text': [398, 413, 437], 'accessPlease': [399], 'review': [400, 745], 'our': [401], 'Terms': [402, 425], 'Conditions': [404, 427], 'Use': [406], 'check': [408], 'box': [409], 'below': [410, 433], 'share': [412, 435], 'version': [414, 438], 'article.I': [416], 'have': [417], 'read': [418], 'accept': [420], 'Wiley': [422], 'Online': [423], 'Library': [424], 'UseShareable': [429], 'LinkUse': [430], 'link': [432], 'a': [436, 451, 457, 461, 493, 551, 565, 582, 589, 643, 691, 710, 744, 839], 'article': [441], 'with': [442, 555, 588, 648, 652, 672, 679, 683, 836, 869, 1006], 'your': [443], 'friends': [444], 'colleagues.': [446], 'Learn': [447], 'more.Copy': [448], 'URL': [449], 'Share': [450], 'linkShare': [452], 'onEmailFacebookTwitterLinkedInRedditWechat': [453], 'Abstract': [454], 'Background': [455], 'Describing': [456], 'index': [459, 473, 713], 'drug': [462, 616, 1003], 'is': [463, 501, 550], 'important': [464], 'evaluating': [466], 'safe': [467], 'effective': [469], 'dosage': [470], 'regimens.': [471], 'Therapeutic': [472], 'can': [474], 'be': [475], 'evaluated': [476], 'as': [477, 564], 'relative': [479], 'position': [480], 'dose-efficacy': [483], 'dose-side': [486], 'curves.': [488], 'Oxybutynin': [489, 504], 'XL': [490, 505, 650, 681, 718], '(Ditropan': [491], 'XL),': [492], 'once-daily': [494], 'oral': [495], 'controlled-release': [496], 'formulation': [497], 'chloride,': [500], 'being': [502], 'developed.': [503], 'efficacy': [506, 548, 647, 859], 'side-effect': [508], 'data': [509, 970], 'obtained': [510], 'from': [511, 971], 'two': [512, 638], 'parallel-group,': [513], 'randomized,': [514], 'controlled': [515, 888], 'clinical': [516], 'trials': [517], 'were': [518], 'modeled': [519, 563, 587], 'index.': [524], 'Methods': [525], 'A': [526, 995], 'nonlinear': [527], 'model': [529, 930], 'was': [530, 561, 586, 598, 604, 618, 634, 642, 676, 694, 714], 'used': [531], 'characterize': [533], 'dose–dry': [538, 707], 'mouth': [539, 572, 663, 671, 708], 'relationship.': [540], 'Weekly': [541], 'urge': [542, 624, 870, 894], 'urinary': [543, 625, 704, 871, 895], 'incontinence': [544, 626, 705], 'episodes,': [545], 'primary': [547], 'variable,': [549], 'discrete': [552], 'variable': [553], '(counts)': [554], 'only': [556], 'non-negative': [557], 'integer': [558], 'values': [559], 'therefore': [562], 'Poisson': [566], 'variable.': [567], 'The': [568, 623, 828], 'probability': [569, 668], 'dry': [571, 670], 'severity': [573], '(the': [574], 'most': [575], 'frequently': [576], 'reported': [577], 'side': [578], 'effect),': [579], 'assessed': [580], 'on': [581, 876], 'categorical': [583, 968], 'four-point': [584], 'scale,': [585], 'proportional': [590], 'odds': [591], 'model.': [592], 'In': [593], 'process,': [596], 'it': [597], 'assumed': [599], 'that': [600, 614, 666], 'time': [602], 'same': [606, 657], 'active': [609], 'placebo': [611], 'treatments': [612], 'additive.': [619], 'Results': [620], 'Conclusions': [622], 'episodes': [627], 'declined': [628], 'log-linearly,': [629], 'no': [631], 'significant': [632], 'difference': [633], 'observed': [635, 695], 'between': [636], 'formulations.': [639], 'However,': [640], 'there': [641], 'trend': [644, 693], 'toward': [645], 'higher': [646], 'than': [651, 682, 719], 'immediate-release': [653, 684, 721], 'at': [655], 'dose': [658, 675], 'in': [659, 686, 696, 756, 801, 833, 867], 'one': [660], 'study.': [661, 699, 842], 'Dose–dry': [662], 'analysis': [664, 1000], 'showed': [665], 'an': [673], 'increasing': [674], 'significantly': [677], 'lower': [678], 'second': [688], 'study,': [689], 'similar': [692], 'first': [698], 'By': [700], 'combining': [701], 'dose–urge': [703], 'relationship,': [709], 'wider': [711], 'predicted': [715], 'oxybutynin.': [722, 787], 'Therapeutics': [726], '(1999)': [727], '672–684;': [729], 'doi:': [730], '10.1016/S0009-9236(99)90089-9': [731], 'References': [732], '1Yarker,': [733], 'Y.': [734], 'E.,': [735], 'Goa,': [736], 'L.': [738, 780, 820, 904, 907, 954, 958, 992], 'Fitton,': [740], '(1995).': [742], 'Oxybutynin:': [743], 'its': [747, 753], 'pharmacodynamic': [748], 'pharmacokinetic': [750], 'properties': [751], 'use': [755], 'detrusor': [757, 831], 'instability.': [758], 'Drugs': [759], 'Aging': [760], '6:': [761], '243–262.': [762], '2Kachur,': [763], 'J.': [764, 767, 770, 817, 850, 921], 'F.,': [765], 'Peterson,': [766], 'S.,': [768, 818], 'Carter,': [769], 'P.,': [771], 'Rzeszotarski,': [772], 'W.': [773], 'J.,': [774], 'Hanson,': [775], 'R.': [776, 881], 'C.': [777], 'Noronha-Blob,': [779], '(1988).': [781], 'R': [782], 'S': [784], 'enantiomers': [785], 'J': [788, 844, 946, 974], 'Pharmacol': [789, 1010], 'Exp': [790], 'Ther': [791, 1011], '247:': [792], '867–872.': [793], '3Jacquetin,': [794], '(1997).': [796, 962], 'Review': [797], 'pharmacological': [799], 'therapy': [800], 'treatment': [803, 829], 'unstable': [806], 'bladder': [807], '[abstract].': [808], 'Acta': [809], 'Obstet': [810, 845], 'Gynecol': [811], 'Scand': [812], '76:': [813], '47.': [814], '4Tapp,': [815], 'Cardozo,': [819], 'D.,': [821], 'Versi,': [822], 'E.': [823], 'Cooper,': [825], 'D.': [826, 924, 981], '(1990).': [827, 926], 'instability': [832], 'post-menopausal': [834], 'women': [835], 'chloride:': [838], 'double-blind': [840], 'placebo-controlled': [841], 'Br': [843], 'Gynaecol': [846], '97:': [847], '521–526.': [848], '5Brown,': [849], '(June': [851], '28-July': [852], '1,': [853], '1998).': [854, 885], 'Comparison': [855], 'tolerability': [857], 'once-a-day': [861, 890], 'vs': [862], 'immediate': [863], 'release': [864], 'chloride': [866, 892], 'patients': [868], 'incontinence.': [872, 896], 'International': [874, 897], 'Consultation': [875], 'Incontinence:': [877], 'Monaco.': [878], '6.': [879], '6Schmidt,': [880], '(Sept': [883], '14–17,': [884], 'Efficacy': [886], 'release,': [889], 'Continence': [898], 'Society:': [899], 'Jerusalem.': [900], '188.': [901], '7Beal,': [902], 'S.': [903, 957], 'Sheiner,': [906], '(1992).': [909], 'NONMEM': [910, 914], "user's": [911], 'guide.': [912], 'UCSF,': [913], 'Project': [915], 'Group:': [916], 'Francisco.': [918], '8Lindstorm,': [919], 'M.': [920, 925], 'Bates,': [923], 'Nonlinear': [927], 'mixed': [928], 'effects': [929], 'repeated': [932], 'measures': [933], 'data.': [934, 945, 987, 1008], 'Biometrics': [935], '46:': [936], '673–687.': [937], '9McCullagh,': [938], 'P.': [939], '(1980).': [940], 'Regression': [941], 'models': [942], 'ordinal': [944], 'Royal': [947], 'Stat': [948, 976], 'Soc': [949], 'B': [950], '42:': [951], '109–142.': [952], '10Sheiner,': [953], 'B.,': [955], 'Beal,': [956], 'Dunne,': [960], 'Analysis': [963], 'nonrandomly': [965], 'censored': [966], 'ordered': [967], 'longitudinal': [969], 'analgesic': [972, 1002], 'trials.': [973], 'Am': [975], 'Assoc': [977], '92:': [978], '1235–1253.': [979], '11Rubin,': [980], '(1976).': [983], 'Inference': [984], 'missing': [986], 'Biometrika': [988], '63:': [989], '581–592.': [990], '12Sheiner,': [991], '(1994).': [994], 'new': [996], 'approach': [997], 'trials,': [1004], 'illustrated': [1005], 'bromfenac': [1007], 'Clin': [1009], '56:': [1012], '309–322.': [1013], 'Citing': [1014], 'Literature': [1015], 'Volume65,': [1016], 'Issue6June': [1017], '1999Pages': [1018], 'ReferencesRelatedInformation': [1020]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2098821956', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 3}, {'year': 2014, 'cited_by_count': 5}, {'year': 2013, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 5}], 'updated_date': '2024-12-14T02:22:14.319814', 'created_date': '2016-06-24'}